Kei Shimizu
Boston Children's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kei Shimizu.
Acta Orthopaedica Scandinavica | 1996
Shuji Ikebe; Shogo Masumi; Hirokazu Yano; Tsutana Fukunaga; Kei Shimizu; Shuta Shin
We examined the immunomodulatory effect of the macrolide antibiotic FK-506 (tacrolimus) in bone xenograft transplantation. Full-thickness pieces of iliac bone from mongrel dogs were transplanted into the iliac bone of Japanese white rabbits. FK-506 at a dose of 1.6 mg/kg/day was injected into the rabbits for 10 days after transplantation. In the animals treated with FK-506, inflammatory cell infiltration was remarkably reduced and revascularization accompanied by new bone formation occurred in the grafts. At 4 months after the transplantation, the formation of new bone and of mature new bone marrow were observed. In a control group, inflammatory cell infiltration was marked around the graft from 2 weeks after the transplantation. Revascularization from the recipient site to the graft in the control group was poor and only a small amount of new bone had formed at 4 months. Our findings suggest that short-term administration of FK-506 has a beneficial effect on experimental xenograft bone transplantation.
Acta Orthopaedica Scandinavica | 1995
Tsutana Fukunaga; Shogo Masumi; Hirokazu Yano; Shuji Ikebe; Kei Shimizu
We investigated osteogenesis and lymphocyte subsets in xenogeneic bone transplantation, using the immunosuppressant FK506 (FK). Iliac bones of rabbits were transplanted as fresh and frozen xenogeneic bone grafts into an intramuscular pouch of rats. FK was injected intramuscularly in half of the rats in a dose of 3 mg/kg/day for 14 days after transplantation. At 2, 4, and 8 weeks, transplanted grafts and the lymphocyte subsets of these rats were examined. In the group not given FK, the grafted bone became necrotic and infiltrated with small round cells around the trabeculae. In the FK group, at 2 and 4 weeks, new bone was formed in the fresh xenografts without infiltration of lymphocytes. At 8 weeks, the new bone became necrotic and lymphocytes were present. The percentage of T cells (CD 5), B cells and the ratio of CD 4 cells/CD 8 cells were smaller in the FK group. Using an immunosuppressant we concluded that xenogeneic bone has an osteogeneic potency.
Orthopaedics and Traumatology | 1988
Kazuhide Tomari; Takehiko Torisu; Yousuke Fujikawa; Keiji Okazaki; Kei Shimizu; Shougo Masumi
We treated three cases of septic arthritis of the knee with loss of articular cartilage in medial compartment of the femoro-tibial joint.One case underwent arthrodesis due to bone loss from medial tibial plateau and unstabl knee.Other two cases had synovectomy, debridement, closed irrigation-suction treatment. They had flexion of 100 degrees or more and no recurrence.Synovectomy, debridement, closed irrigation-suction treatment is effective for septic arthritis of the knee with stability and intact articular cartilage in one compartment even if articular cartilage in another compartment is defected.
Japanese Journal of Clinical Oncology | 1991
Hitoshi Uchida; Shigeo Yokoyama; Kenji Kashima; Iwao Nakayama; Kei Shimizu; Shogo Masumi
Annals of Transplantation | 2001
Kei Shimizu; Hirokazu Yano; Eizirou Nakamura; Nobuhiro Kaku
Acta Orthopaedica Scandinavica | 1996
Shouichi Uchinou; Hirokazu Yano; Kei Shimizu; Shogo Masumi
Orthopaedics and Traumatology | 1995
Shouichi Uchinou; Mitsuhiro Takasita; Kei Hirakawa; Katsuhiro Tada; Kei Shimizu; Hirofumi Taira; H. Kida
Orthopaedics and Traumatology | 1996
Kei Shimizu; Hirokazu Yano; Tsutana Fukunaga; Shuji Ikebe; Shogo Masumi
Orthopaedics and Traumatology | 1995
Shouichi Uchinou; Mitsuhiro Takashita; Masahiko Nakamura; Katsuhiro Tada; Kei Shimizu; Mitsukane Kumagi; Shougo Masumi
Orthopaedics and Traumatology | 1992
Kazuhisa Nanamori; Takehiko Torisu; Kei Shimizu; Tunenori Asao; Shougo Masumi